000 | 01332 a2200421 4500 | ||
---|---|---|---|
005 | 20250513211022.0 | ||
264 | 0 | _c20000718 | |
008 | 200007s 0 0 eng d | ||
022 | _a1049-5118 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuir, A J | |
245 | 0 | 0 |
_aThe natural history of hepatitis C viral infection. _h[electronic resource] |
260 |
_bSeminars in gastrointestinal disease _cApr 2000 |
||
300 |
_a54-61 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xepidemiology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xepidemiology |
650 | 0 | 4 |
_aHepatitis C _xdiagnosis |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Cirrhosis _xepidemiology |
650 | 0 | 4 |
_aLiver Neoplasms _xepidemiology |
650 | 0 | 4 | _aLiver Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aUnited States _xepidemiology |
773 | 0 |
_tSeminars in gastrointestinal disease _gvol. 11 _gno. 2 _gp. 54-61 |
|
999 |
_c10755524 _d10755524 |